TP53 and breast carcinoma: A total of 15 of 49 inherited breast cancer cases in which a discussion to opt for risk-reduction mastectomy (RRM) was recommended given the mutated gene (i.e., BRCA1, BRCA2, TP53, PALB2, and PTEN) made the decision to undergo this procedure (30.6%).